BEUDAMED
    14 results · 17ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Classification ×

    Cement, Ear, Nose And Throat

    FDA classification
    FDA Class 2 ·Cement, Ear, Nose And Throat

    Tlc Chromatographic Separation Triglycerides

    FDA classification
    FDA Class 1 ·Tlc Chromatographic Separation Triglycerides

    Myoglobin, Fitc, Antigen, Antiserum, Control

    FDA classification
    FDA Class 2 ·Myoglobin, Fitc, Antigen, Antiserum, Control

    System, Test, Her-2/Neu, Ihc

    FDA classification
    FDA Class 3 ·System, Test, Her-2/Neu, Ihc

    System, Test, Her-2/Neu, Monitoring

    FDA classification
    FDA Class 2 ·System, Test, Her-2/Neu, Monitoring

    Control Material, Her-2/Neu, Immunohistochemistry

    FDA classification
    FDA Class 2 ·Control Material, Her-2/Neu, Immunohistochemistry

    Eas Chromatography, Quinine

    FDA classification
    FDA Class 1 ·Eas Chromatography, Quinine

    Prescription Use Blood Glucose Meter For Near-Patient Testing

    FDA classification
    FDA Class 2 ·Prescription Use Blood Glucose Meter For Near-Patient Testing

    System, Test, Her-2/Neu, Nucleic Acid Or Serum

    FDA classification
    FDA Class 3 ·System, Test, Her-2/Neu, Nucleic Acid Or Serum

    Electronic Article Surveillance (Eas)

    FDA classification
    FDA Not Classified ·Electronic Article Surveillance (Eas)

    Anti-Theft Detector (Non-Eas)

    FDA classification
    FDA Not Classified ·Anti-Theft Detector (Non-Eas)

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA classification
    FDA Class 3 ·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings